The startup operates a healthcare research and development platform that integrates real-world health and genomic data for observational studies and clinical trials. By providing insights into individual health and genetic ancestry, the platform enhances drug development and health care decision-making.
Funding
Funding not disclosed
Founders
Product
Problem
Current healthcare research often lacks comprehensive datasets that integrate real-world health records with genomic information, hindering the discovery of novel therapeutic targets and effective diagnostic tools. The underrepresentation of diverse communities in these datasets further limits the generalizability and applicability of research findings across different populations.
Solution
Omnigen Biodata is developing a research platform called Discover Me that integrates health records with genomic data from diverse populations to accelerate healthcare innovation. The platform facilitates the discovery of new drug targets, improves clinical trial design, and enables personalized healthcare approaches. By partnering with healthcare providers and engaging the public, Omnigen is building a global research community that promotes trust, ethics, and data security. Participants in the Discover Me study gain access to summaries of their health and ancestry information, empowering them to make informed healthcare decisions.
Target Audience
The primary target audience includes healthcare organizations, pharmaceutical companies, and research institutions seeking to accelerate drug discovery, improve clinical trial outcomes, and develop personalized healthcare solutions.
Features
- Integration of electronic health records (EHR) with genomic data
- Recruitment of diverse communities to ensure representative datasets
- GDPR compliance and robust privacy framework to protect participant data
- Independent ethical review by government-recognized committees and institutional review boards
- Secure data environment with robust privacy technologies and strong governance
- Algorithms to improve patient care and services
- Identification of novel targets for new medicines and diagnostic tools
- Support for better clinical trial design and participant referral, including for rare diseases